As technology develops, experimental boundaries are being pushed further and further. Discoveries that were considered ground-breaking as little as five years ago are today considered routine. In this article, we examine the ever-more stringent inventive step/obviousness requirements of the European and US patent offices.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soames, C., Kowalski, T. Inventive step and genomics. Nat Rev Drug Discov 3, 729 (2004). https://doi.org/10.1038/nrd1503
Issue date:
DOI: https://doi.org/10.1038/nrd1503
